Indaptus Therapeutics (INDP) Institutional Ownership → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free INDP Stock Alerts $2.35 -0.14 (-5.62%) (As of 04/24/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Indaptus Therapeutics (NASDAQ:INDP)CurrentInstitutional OwnershipPercentage7.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$24.17KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$34.07K Get INDP Insider Trade Alerts Want to know when executives and insiders are buying or selling Indaptus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INDP Institutional Buying and Selling by Quarter Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… Indaptus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/9/2023Investment House LLC102,849$283K0.0%-5.0%1.224% 8/25/2023Strategy Asset Managers LLC45,336$87K0.0%-18.1%0.540% 8/8/2023Investment House LLC108,282$207K0.0%+13.2%1.289% 10/11/2022Strategy Asset Managers LLC55,336$120K0.0%N/A0.670% 7/22/2022 Stratos Wealth Partners LTD.26,832$70K0.0%-97.7%0.325% 4/26/2022 Stratos Wealth Partners LTD.1,188,356$4.75M0.1%-14.4%14.389% 2/9/2022Investment House LLC95,629$545K0.0%+272.8%1.167% 1/14/2022 Stratos Wealth Partners LTD.1,388,356$7.91M0.2%N/A16.952% 11/15/2021Marshall Wace LLP12,780$100K0.0%N/A0.236% 10/25/2021Harel Insurance Investments & Financial Services Ltd.2,958$25K0.0%N/A0.055% (Data available from 1/1/2016 forward) INDP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INDP shares? During the previous two years, the following institutional investors and hedge funds held shares of Indaptus Therapeutics shares: Investment House LLC ($283K), and Strategy Asset Managers LLC ($87K), Stratos Wealth Partners LTD. ($70K).Learn more on INDP's institutional investors. What percentage of Indaptus Therapeutics stock is owned by institutional investors? 7.06% of Indaptus Therapeutics stock is owned by institutional investors. Learn more on INDP's institutional investor holdings. Which institutional investors have been buying Indaptus Therapeutics stock? The following institutional investors have purchased Indaptus Therapeutics stock in the last 24 months: Strategy Asset Managers LLC ($55.34K), and Investment House LLC ($12.65K). How much institutional buying is happening at Indaptus Therapeutics? Institutional investors have bought a total of 67,989 shares in the last 24 months. This purchase volume represents approximately $143.69K in transactions. Which Indaptus Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Indaptus Therapeutics stock in the last 24 months: Stratos Wealth Partners LTD. ($1.36M), Strategy Asset Managers LLC ($10K), and Investment House LLC ($5.43K). How much institutional selling is happening at Indaptus Therapeutics? Institutional investors have sold a total of 1,376,957 shares in the last 24 months. This volume of shares sold represents approximately $3.87M in transactions. Related Companies: ONCT Major Shareholders BFRG Major Shareholders ITRM Major Shareholders LSTA Major Shareholders ADXN Major Shareholders NRSN Major Shareholders DRRX Major Shareholders BIOR Major Shareholders CPIX Major Shareholders SNSE Major Shareholders This page (NASDAQ:INDP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
